Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02425384 · ClinicalTrials.gov registry record · NA
Accelerometer-linked Online Intervention to Promote Physical Activity in Adolescents
A NA study of Health Behavior and Adolescent Behavior, sponsored by HopeLab Foundation.
- Completed
- Registry status
- NA
- Development phase
- 182
- Enrollment target
- 3
- Study locations
NCT02425384: Completed NA study of Health Behavior and Adolescent Behavior, sponsored by HopeLab Foundation.
NCT02425384 is a NA study of Health Behavior and Adolescent Behavior that has completed, run by HopeLab Foundation. The registered enrollment target is 182 participants, below the 2,183-participant average among 65 other Health Behavior trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02425384, a NA study of Health Behavior and Adolescent Behavior, has completed, sponsored by HopeLab Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary objective of this protocol is to test whether an activity monitor with an online motivational rewards component will increase physical activity levels of middle school-aged students. The secondary objective is to learn about the functionality and utilization of the activity meter device among this age group.
Primary Outcome
The amount and intensity of physical activity is recorded continuously every study day that participants wear the provided activity meter for the 6 weeks study. The primary outcome reported will be rates of "moderate to vigorous" physical activity.
Conditions Studied
Interventions
- BEHAVIORAL Intervention Group (motivational website, activity meter)
- BEHAVIORAL Active Control (active video game, activity meter)
- OTHER Passive Control (activity meter)
Study Locations (3)
California
- Crittenden Middle School - Mountain View
- Vista Middle School - Vista
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-06 |
| Phase | NA |
What the finished NCT02425384 record still lists
NCT02425384 is an interventional study that assigns participants to a tested intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, below the 2,183-participant average among 65 other Health Behavior trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Health Behavior appearing as the primary indexed condition, and to 3 interventions - of which Intervention Group (motivational website, activity meter) is the first listed.
NCT02425384 reports a single indexed study location in California, West Virginia.
Frequently Asked Questions
What is clinical trial NCT02425384 about?
NCT02425384 is a clinical study titled "Accelerometer-linked Online Intervention to Promote Physical Activity in Adolescents". The primary objective of this protocol is to test whether an activity monitor with an online motivational rewards component will increase physical activity levels of middle school-aged students. The secondary objective is to learn about the functionality and utilization of the activity meter device ...
What is the current status of trial NCT02425384?
This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2008-10. Estimated completion is 2009-06.
What conditions does trial NCT02425384 study?
This clinical trial studies the following conditions: Health Behavior, Adolescent Behavior, Motivation.
What interventions are being tested in trial NCT02425384?
The interventions under investigation include: Intervention Group (motivational website, activity meter) (BEHAVIORAL), Active Control (active video game, activity meter) (BEHAVIORAL), Passive Control (activity meter) (OTHER).
Who is sponsoring clinical trial NCT02425384?
This trial is sponsored by HopeLab Foundation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02425384 being conducted?
This trial has 3 study locations across California, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02425384's enrollment target sits among peer trials
182 34th of 65 higher than 32 of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sugary Drink Labeling Study
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Validation Study of Bioelectronics
RECRUITING · NA
-
A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia